101 related articles for article (PubMed ID: 11746178)
1. Replacement of surgical castration by GnRH inhibition for rat prostate androgen receptor preparations.
Ashby J; Lefevre PA
J Appl Toxicol; 2001; 21(5):353-4. PubMed ID: 11746178
[No Abstract] [Full Text] [Related]
2. Synergistic effect of testosterone and of a luteinizing hormone-releasing hormone agonist on androgen receptor content in the ventral prostate of castrated rats.
Fiorelli G; Zoppi S; Kohen F; Motta M
Steroids; 1989; 53(1-2):195-217. PubMed ID: 2505407
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
[TBL] [Abstract][Full Text] [Related]
4. Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues.
Raynaud JP; Bonne C; Bouton MM; Lagace L; Labrie F
J Steroid Biochem; 1979 Jul; 11(1A):93-9. PubMed ID: 385986
[No Abstract] [Full Text] [Related]
5. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881).
van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT
J Androl; 1997; 18(1):51-61. PubMed ID: 9089068
[TBL] [Abstract][Full Text] [Related]
7. Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate.
Prins GS
Endocrinology; 1987 Apr; 120(4):1457-64. PubMed ID: 3493896
[TBL] [Abstract][Full Text] [Related]
8. Replacement of surgical castration by GnRH-inhibition or Leydig cell ablation in the male rat Hershberger antiandrogen assay.
Ashby J; Lefevre PA; Deghenghi R; Wallis N
Regul Toxicol Pharmacol; 2001 Oct; 34(2):188-203. PubMed ID: 11603962
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prostate gene expression and tissue weight changes as monitors of antiandrogen activity in GNRH-inhibited rats.
Nellemann C; Lefevre PA; Ashby J
Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):344-54. PubMed ID: 14666997
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the selectivity and efficiency of target tissue uptake of five tritium-labeled androgens in the rat.
Carlson KE; Katzenellenbogen JA
J Steroid Biochem; 1990 Aug; 36(6):549-61. PubMed ID: 2214772
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells.
Culig Z; Hobisch A; Hittmair A; Cronauer MV; Radmayr C; Zhang J; Bartsch G; Klocker H
Prostate; 1997 Jul; 32(2):106-14. PubMed ID: 9215398
[TBL] [Abstract][Full Text] [Related]
12. [Can mepartricin be considered an antiandrogenic drug?].
Lubrano C; Bianchi P; Verna T
Minerva Urol Nefrol; 1992; 44(2):113-6. PubMed ID: 1384153
[No Abstract] [Full Text] [Related]
13. The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.
Ghanadian R; Smith CB; Williams G; Chisholm GD
Br J Urol; 1977; 49(7):695-700. PubMed ID: 74269
[TBL] [Abstract][Full Text] [Related]
14. Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis .
Shen R; Lin MC; Sadeghi F; Swerdloff RS; Rajfer J; Gonzalez-Cadavid NF
J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):301-13. PubMed ID: 8639466
[TBL] [Abstract][Full Text] [Related]
15. Exchange assay for androgen receptors in the presence of molybdate.
Carroll SL; Rowley DR; Chang CH; Tindall DJ
J Steroid Biochem; 1984 Oct; 21(4):353-9. PubMed ID: 6387280
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.
Maudsley S; Davidson L; Pawson AJ; Freestone SH; López de Maturana R; Thomson AA; Millar RP
Neuroendocrinology; 2006; 84(5):285-300. PubMed ID: 17202804
[TBL] [Abstract][Full Text] [Related]
17. Suppression of steroid receptor-chromatin interaction by inhibitors present in ammonium sulfate-fractionated rat testicular androgen receptor preparations.
Tsai YH
J Androl; 1987; 8(5):299-306. PubMed ID: 3499428
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]-methyltrienolone (R1881) by human breast cancers.
Miller WR; Telford J; Hawkins RA
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1473-8. PubMed ID: 6605855
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a panel of rat ventral prostate epithelial cell lines immortalized in the presence or absence of androgens.
Rundlett SE; Gordon DA; Miesfeld RL
Exp Cell Res; 1992 Nov; 203(1):214-21. PubMed ID: 1330656
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor in rat liver: characterization and separation from a male-specific estrogen-binding protein.
Eagon PK; Seguiti SM; Rogerson BJ; McGuire TF; Porter LE; Seeley DH
Arch Biochem Biophys; 1989 Jan; 268(1):161-75. PubMed ID: 2783543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
